Key features
- User friendly
- Automatized bioinformatics analysis of NGS data
- Advanced quality control of sequencing data
- Easy variants filtration
- Local Clinical Variants Database
- Visualization of NGS data
- Internal interpretation of variants and sharing between clinics
- Clinical report generation
GENOVESA enables evaluation of data from small panels, through clinical exome (CES) whole exome data (WES) to whole genome sequencing (WGS) data. It includes a wide range of annotation databases and the possibility of individual customization. FASTQ, BAM and VCF data quality control. Possibility of own interpretation of variants and comments.
Complete clinical management with integration of International Classification of Diseases (ICD) and HPO terminology.
Sequencing technology
GENOVESA enables analysis of conventional sequencing data (FASTQ, BAM, VCF) regardless of what sequencing technology was used – Illumina, MGI, PacBio, Oxford Nanopore Technologies, Genapsys and many others.
Databases and data sharing
GENOVESA also serves as a database for storing variants, with the possibility of sharing data between individual clinics.
Security
GENOVESA prioritizes data security through HTTPS encryption. We do not rely on third-party providers like Google or Amazon; instead, we host your data in our secure data center located in Prague. We do not collect any sensitive patient data, GENOVESA is fully GDPR compliant.
